France (FR)

A beta-barrel for oil transport through lipid membranes: Dynamic NMR structures of AlkL (2020) Castiglione K, Schubeis T, Marchand L, Daday C, Kopec W, Movellan KT, Stanek J, et al. Journal article 3D Morphable Face Modelsa-Past, Present, and Future (2020) Egger B, Smith WAP, Tewari A, Wuhrer S, Zollhoefer M, Beeler T, Bernard F, et al. Journal article Characterization of Carbon Materials for Hydrogen Storage and Compression (2020) Sdanghi G, Canevesi RLS, Celzard A, Thommes M, Fierro V Journal article, Review article Characteristics of the first 615 patients enrolled in Pacific R: A study of the first real-world data on unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy (2020) Girard N, Fietkau R, Garassino M, Garrido P, Field JK, Peters S, Smit HJM, et al. Conference contribution EPIK-B3: A phase III, randomised, double-blind (DB), placebo (PBO)-controlled study of alpelisib (ALP) plus nab-paclitaxel (nabPTX) in advanced triple-negative breast cancer (TNBC) with either PIK3CA mutation or phosphatase and tensin homolog (PTEN) loss without PIK3CA mutation (2020) Sharma P, Farooki A, Fasching P, Loi S, Peterson K, Prat A, Tripathy D, et al. Conference contribution Efficacy and safety of lanreotide autogel (LAN) 120 mg every 14 days in progressive pancreatic or midgut neuroendocrine tumours (NETs): CLARINET FORTE study results (2020) Pavel ME, Cwikla JB, Lombard-Bohas C, Borbath I, Shah T, Pape UF, Thanh XMT, et al. Conference contribution Clinical characteristics and outcomes of coronavirus 2019 disease (COVID-19) in cancer patients treated with immune checkpoint inhibitors (ICI). (2020) Rogiers A, Tondini C, Grimes JM, Trager MH, Nahm S, Zubiri L, Papneja N, et al. Conference contribution Evolution of Magmatism in the New Hebrides Island Arc and in Initial Back-Arc Rifting, SW Pacific (2020) Haase K, Gress MU, Lima S, Regelous M, Beier C, Romer RL, Bellon H Journal article Prospective Multicenter BAL Study: Focus real-time PCR (2020) Springer J, Rickerts V, Teschner D, Kessel J, Liebregts T, Cornely A, Schwartz S, et al. Conference contribution Development of an immunological prognostic Signature in metastatic Patients who were treated with Immune Checkpoint Inhibitors as part of the ST-ICI Study (2020) Zhou J, Donaubauer AJ, Frey B, Becker I, Rutzner S, Sun R, Ma H, et al. Conference contribution